1st Jul 2013 16:55
Notification of Transactions of Directors, Persons Discharging
Managerial Responsibility or Connected Persons
The Administrators of the GlaxoSmithKline 2009 Performance Share Plan notified the Company and the under-mentioned persons on 28 June 2013 of the following increases in their notional interests in Ordinary Shares at a price of 1565.50 pence per Ordinary Share and American Depositary Shares (ADSs) at a price of $48.52 per ADS following the notional re-investment of the dividend paid to shareholders on 11 April 2013.
Ordinary Shares | ADSs | |
Sir Andrew Witty | 6,151.624 | |
Dr M M Slaoui | 1,897.363 | |
Mr S Dingemans | 2,706.794 | |
Mr S M Bicknell | 591.492 | |
Mr R G Connor | 1,159.796 | |
Mrs D P Connelly | 785.783 | |
Mr S A Hussain | 2,319.605 | |
Mr W C Louv | 556.586 | |
Mr D S Redfern | 889.177 | |
Ms C Thomas | 1,256.452 | |
Mr P C Thomson | 599.221 | |
Mr D E Troy | 1,187.662 | |
Dr P J T Vallance | 2,706.218 | |
Ms E Walmsley | 1,546.408 | |
Mr C Weber | 552.523 | |
Mrs V A Whyte | 165.826 |
The notional dividends accrued will be paid out in proportion to the percentage of participants' Performance Share Plan holdings that vest following the end of the relevant three-year measurement period.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
1 July 2013
Related Shares:
Glaxosmithkline